Evaluation eines dominantnegativen rekombinanten Herpes-simplex-Virus (HSV) Typ 1 als Impfstoff gegen Herpes genitalis bei Mäusen und Meerschweinchen - Evaluation of a dominant-negative recombinant herpes simplex virus (HSV) type 1 as a vaccine against genital herpes in mice und guinea pigs
Brans, R.
der Hautarzt 61(12): 1073-1077
2010
ISSN/ISBN: 0017-8470 Accession: 075327548
PDF emailed within 1 workday: $29.90
Related References
Brans, R. 2010: Evaluation of a dominant-negative recombinant herpes simplex virus (HSV) type 1 as a vaccine against genital herpes in mice und guinea pigs Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 61(12): 1073-1078Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Rabenau, H. F.; Helmerich, A.; Weber, B. 1999: Verbesserte Labordiagnose der Herpes simplex Virus Infektion: Evaluierung eines modifizierten schnellen Shell-Vial-Assays zur Detektion und Typisierung von Herpes simplex Viren. Improved Laboratory Diagnosis of Herpes Simplex Virus Infection: Evaluation of a Modified Rapid Shell-Vial-Assay for the Detection and Typing of Herpes Simplex Virus Laboratoriums Medizin 23(11): 614-620
Scriba, M. 1978: Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine Medical Microbiology and Immunology 166(1-4): 63-69
Heineman, T.C.; Connelly, B.L.; Bourne, N.; Stanberry, L.R.; Cohen, J. 1995: Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs Journal of Virology 69(12): 8109-8113
Hoshino, Y.; Pesnicak, L.; Dowdell, K.C.; Lacayo, J.; Dudek, T.; Knipe, D.M.; Straus, S.E.; Cohen, J.I. 2008: Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs Vaccine 26(32): 4034-4040
Brans, R.; Yao, F. 2010: Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs Bmc Microbiology 10: 163
Kimura, S.; Okazaki, K. 1984: Expression of a herpes simplex virus glycoprotein in two clonal lines of hamster cells transformed by herpes simplex virus type 2 - Expression d'une glycoprotéine du virus herpès simplex dans deux lignées clonales de cellules de hamster transformées par le virus herpès simplex de type 2 Gann 75(4): 317-324
Chen, M.H.; W.J.G.; Skinner, G.R.B.; Hartley, C.E. 1984: Failing in prevention of herpes simplex virus type 2 latency in sensory ganglia of mice with an inactivated subunit vaccine ac nfu 1 s negative bhk prepared from herpes simplex virus type 1 Journal of Cellular Biochemistry Suppl (8 Part B): 205
Stanberry, L.R.; Bernstein, D.T.; Burke, R.L.; Pachl, C.A.; Myers, M.G. 1986: Herpes simplex virus subunit vaccines effect on initial and recurrent genital herpes simplex virus 2 disease in guinea pigs Pediatric Research 20(4 Part 2): 322A
Althof, F.; Mechtersheimer, M.; Richter, M.; Dietz, A. 2000: Ein Herpes-simplex-Virus Typ 1-induzierter, Tumor im Vestibulum nasi: Die Problematik der Resistenzentwicklung von Herpes-simplex-Viren im Rahmen einer chronisch-lymphatischen B-Zell-Leukämie - Herpes simplex virus type 1-induced, tumor in the nasal vestibule.the problem of resistance development of herpes simplex in a patient with chronic lymphatic B-cell leukemia Hno. Hals-, Nasen-, Ohrenarzte 48(2): 147-151
Maragos, C.; Miller, A.; May, J.T. 1986: Antibody response to the herpes simplex virus type 2 AG-4 antigen in guinea pigs with genital herpes infections Australian Journal of Experimental Biology and Medical Science 64: 89-95
Maragos, C.; Miller, A.; May, J.T. 1986: Antibody response to the herpes simplex virus type 2 ag 2 antigen and guinea pigs with genital herpes infections Australian Journal of Experimental Biology and Medical Science 64(1): 89-96
Aurelian, L.; Smith, C.C.; Wachsman, M.; Paoletti, E. 1991: Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D Reviews of Infectious Diseases 13(Suppl 11): S924-S934
Spector, F.C.; Kern, E.R.; Palmer, J.; Kaiwar, R.; Cha, T.A.; Brown, P.; Spaete, R.R. 1998: Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs Journal of Infectious Diseases 177(5): 1143-1154
Spector, F..; Kern, E..; Palmer, J.; Kaiwar, R.; Cha, T. A.; Brown, P.; Spaete, R.. 1998: Evaluation of a Live Attenuated Recombinant Virus Rav 9395 as a Herpes Simplex Virus Type 2 Vaccine in Guinea Pigs The Journal of Infectious Diseases 177(5): 1143-1154
Carter, V.C.; Jennings, S.R.; Rice, P.L.; Tevethia, S.S. 1984: Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes Journal of Virology 49(3): 766-771
Meier, J.; Corey, L.; Burke, R.L.; Savarese, B.; Barnum, G.; Kost, R.; Adair, S.; Dekker, C.; Straus, S.E. 1993: Immunotherapy of genital herpes with a recombinant herpes simplex virus type 2 glycoprotein D vaccine A placebo-controlled trial Clinical Research 41(2): 199A
Zhang, P.; Xie, L.; Balliet, J.W.; Casimiro, D.R.; Yao, F. 2014: A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs Plos one 9(6): E101373
Prichard, M.N.; Kaiwar, R.; Jackman, W.T.; Kern, E.R.; Quenelle, D.C.; Collins, D.J.; Herrod, B.P.; Gustin, K.M.; Kemble, G.M.; Spaete, R.R. 2003: Evaluation of a recombinant live attenuated herpes simplex virus type 2 vaccine in guinea pigs Antiviral Research 57(3): A58